These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20082583)

  • 41. Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.
    Elleri D; Allen JM; Nodale M; Wilinska ME; Acerini CL; Dunger DB; Hovorka R
    Diabet Med; 2010 Apr; 27(4):480-4. PubMed ID: 20536523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
    Tauschmann M; Thabit H; Bally L; Allen JM; Hartnell S; Wilinska ME; Ruan Y; Sibayan J; Kollman C; Cheng P; Beck RW; Acerini CL; Evans ML; Dunger DB; Elleri D; Campbell F; Bergenstal RM; Criego A; Shah VN; Leelarathna L; Hovorka R;
    Lancet; 2018 Oct; 392(10155):1321-1329. PubMed ID: 30292578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.
    Kropff J; DeJong J; Del Favero S; Place J; Messori M; Coestier B; Farret A; Boscari F; Galasso S; Avogaro A; Bruttomesso D; Cobelli C; Renard E; Magni L; DeVries JH;
    Diabet Med; 2017 Feb; 34(2):262-271. PubMed ID: 27696520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
    Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
    Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial.
    Nimri R; Muller I; Atlas E; Miller S; Fogel A; Bratina N; Kordonouri O; Battelino T; Danne T; Phillip M
    Diabetes Care; 2014 Nov; 37(11):3025-32. PubMed ID: 25078901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
    Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
    N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous Blood Glucose Monitoring Increases Vigorous Physical Activity Levels and Is Associated With Reduced Hypoglycemia Avoidance Behavior In Youth With Type 1 Diabetes.
    Jabbour G; Bragazzi NL
    Front Endocrinol (Lausanne); 2021; 12():722123. PubMed ID: 34557162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting.
    Renard E; Tubiana-Rufi N; Bonnemaison-Gilbert E; Coutant R; Dalla-Vale F; Farret A; Poidvin A; Bouhours-Nouet N; Abettan C; Storey-London C; Donzeau A; Place J; Breton MD
    Diabetes Obes Metab; 2019 Jan; 21(1):183-187. PubMed ID: 30047223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical activity and sedentary behavior levels in children and adolescents with type 1 diabetes using insulin pump or injection therapy - The importance of parental activity profile.
    Michaud I; Henderson M; Legault L; Mathieu ME
    J Diabetes Complications; 2017 Feb; 31(2):381-386. PubMed ID: 27989545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feasibility of overnight closed-loop control based on hourly blood glucose measurements.
    Patte C; Pleus S; Galley P; Weinert S; Haug C; Freckmann G
    J Diabetes Sci Technol; 2012 Jul; 6(4):902-9. PubMed ID: 22920817
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes.
    O'Grady MJ; Retterath AJ; Keenan DB; Kurtz N; Cantwell M; Spital G; Kremliovsky MN; Roy A; Davis EA; Jones TW; Ly TT
    Diabetes Care; 2012 Nov; 35(11):2182-7. PubMed ID: 22875230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial.
    Tauschmann M; Allen JM; Wilinska ME; Ruan Y; Thabit H; Acerini CL; Dunger DB; Hovorka R
    J Diabetes Sci Technol; 2017 May; 11(3):513-521. PubMed ID: 27837162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
    Alsaleh FM; Smith FJ; Taylor KM
    J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes.
    Mitchell K; Johnson K; Cullen K; Lee MM; Hardy OT
    Diabetes Technol Ther; 2013 Jul; 15(7):591-5. PubMed ID: 23799273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.